Healthcare

EKR Therapeutics

March 2008
Bedminster, PA / Growth Capital

Latest Insights & News

• Drug Marketer has $50M Equity Round

EKR is a specialty pharmaceutical company providing novel products that offer broad therapeutic potential and superior outcomes to acute-care hospitals. EKR was acquired by Cornerstone Therapeutics in June 2012.

Status

Realized

View All Companies